Summary
Profile
Financials
Events
Ownership
Options

Company Info

Industry n/a
Sector n/a
Employees n/a
CEO n/a
Address , ,
Phone n/a
Website n/a

Competitors

Company Name 3 Month
%Change
1 Year
%Change
No competitor information is available.

Statement Summary

as of 3:59 ET PM 10/25/2021
Total Assets (MRQ) 218.5 M
Total Liabilities (MRQ) 250.8 M
Shareholders’ Equity (MRQ) n/a
Total Revenue (Annual) 34.7 M
Net Income (Annual) -20.7 M

Earnings And Estimates

as of 3:59 ET PM 10/25/2021

Current Qtr EPS Estimate n/a
Current FY EPS Estimate n/a
Long Term EPS Growth Estimate n/a
Next Expected Earnings Date //

MVEN vs S&P 500

as of 10/25/2021
Relative To
S&P 500
MVEN
4 Weeks n/a n/a
12 Weeks n/a n/a
YTD n/a n/a

Earnings Surprises

as of 3:59 ET PM 10/25/2021
Fiscal Quarter Estimate Actual Surprise

Financial Strength

as of 3:59 ET PM 10/25/2021
Pre-Tax Margin -59.45
Net Margin 40.73
Operating Margin -66.95
Return On Equity 0.00
Return On Assets -43.09
Inventory Turnover (TTM) 0.00
Sales Growth (MRQ) n/a

Ratios

as of 3:59 PM ET 10/25/2021
Price/Earnings (TTM) n/a
Price/Book (MRQ) 0.00
Price/Cash Flow (TTM) 0.00
Book Value (MRQ) -0.12
Quick Ratio (MRQ) 0.38
Current Ratio (MRQ) 0.38
Total Debt/Equity (MRQ) 0.00

Short Interest

as of 10:38 AM ET 10/26/2021
% Short - 0.00%
% Remaining Float - 100.00%
Current Last Month
Short Interest Date n/a n/a
Short Interest Shares n/a n/a
Short Interest Ratio n/a n/a
M Y M Y
Total Assets 0,0.00 0,0.00
Total Liabilities 0,0.00 0,0.00
Total Equity 0,0.00 0,0.00
M Y M Y
Total Revenue 0,0.00 0,0.00
EBT Exc.
Unusual Items
0,0.00 0,0.00
Net Income 0,0.00 0,0.00
M Y M Y
Cash from
Operations
0,0.00 0,0.00
Cash from
Activities
0,0.00 0,0.00
Cash from
Fin. Activities
0,0.00 0,0.00

TOTAL ASSETS

TOTAL LIABILITIES

TOTAL EQUITY

Balance Sheet

M Y
ASSETS
Cash And Equivalents 0,0.00
Receivables 0,0.00
Inventories 0,0.00
Other Current Assets 0,0.00
Total Current Assets 0,0.00
Property, Plant & Equipment, Gross 0,0.00
Accumulated Depreciation & Depletion 0,0.00
Property, Plant & Equipment, Net 0,0.00
Intangibles 0,0.00
Other Non-Current Assets 0,0.00
Total Non-Current Assets 0,0.00
TOTAL ASSETS 0,0.00
Liabilities & Shareholder Equity
Accounts Payable 0,0.00
Short Term Debt 0,0.00
Total Current Liabilities 0,0.00
Long Term Debt 0,0.00
Deferred Income Taxes 0,0.00
Other Non-Current Liabilities 0,0.00
Minority Interest 0,0.00
Total Non-Current Liabilities 0,0.00
Preferred Stock Equity 0,0.00
Common Stock Equity 0,0.00
Common Par 0,0.00
Additional Paid In Capital 0,0.00
Cumulative Translation Adjustment 0,0.00
Retained Earnings 0,0.00
Treasury Stock 0,0.00
Other Equity Adjustments 0,0.00
Total Capitalization 0,0.00
TOTAL EQUITY 0,0.00
TOTAL LIABILITIES & STOCK EQUITY 0,0.00
Total Common Shares Outstanding 0,0.00
Preferred Shares 0,0.00
Treasury Shares 0,0.00
Basic Weighted Shares Outstanding 0,0.00
Diluted Weighted Shares Outstanding 0,0.00
Number Of Employees 0,0.00
Number Of Part-Time Employees 0,0.00

TOTAL REVENUES

EBT Excluding Unusual Items

NET INCOME

Income Statement

M Y
Sales 0,0.00
Cost Of Sales 0,0.00
Gross Operating Profit 0,0.00
Selling, General, And Administrative Expenses 0,0.00
Research & Development 0,0.00
Operating Income Before D & A (EBITDA) 0,0.00
Depreciation & Amortization 0,0.00
Interest Income 0,0.00
Other Income - Net 0,0.00
Special Income / Charges 0,0.00
Total Income Before Interest Expenses (EBIT) 0,0.00
Interest Expense 0,0.00
Pre-Tax Income 0,0.00
Income Taxes 0,0.00
Minority Interest 0,0.00
Net Income From Continuing Operations 0,0.00
Net Income From Discontinued Operations 0,0.00
Net Income From Total Operations 0,0.00
Extraordinary Income/Losses 0,0.00
Income From Cum. Effect Of Acct. Change 0,0.00
Income From Tax Loss Carryforward 0,0.00
Other Gains / Losses 0,0.00
Total Net Income 0,0.00
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0,0.00
Preferred Dividends 0,0.00
Net Income Available To Common 0,0.00
Basic EPS From Continuing Ops. 0,0.00
Basic EPS From Discontinued Ops. 0,0.00
Basic EPS From Total Operations 0,0.00
Basic EPS From Extraordinary Inc. 0,0.00
Basic EPS From Cum Effect Of Accounting Change 0,0.00
Basic EPS From Tax Loss Carryf'd. 0,0.00
Basic EPS From Other Gains (Losses) 0,0.00
Basic EPS, Total 0,0.00
Basic Normalized Net Income/Share 0,0.00
EPS From Continuing Ops. 0,0.00
EPS From Discontinued Ops 0,0.00
EPS From Total Ops. 0,0.00
EPS From Extraord. Inc. 0,0.00
EPS From Cum Effect of Accounting Change 0,0.00
EPS From Tax Loss Carfd. 0,0.00
EPS From Other Gains (L) 0,0.00
EPS, Total 0,0.00
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0,0.00
Dividends Paid Per Share 0,0.00

CASH FROM OPERATIONS

CASH FROM INVESTING ACTIVITIES

CASH FROM FINANCING ACTIVITIES

Cash Flow Statement

M Y
Cash Flow From Operating Activities
Net Income (Loss) 0,0.00
Operating Gains/Losses 0,0.00
Gross Operating Profit 0,0.00
(Increase) Decrease In Receivables 0,0.00
(Increase) Decrease In Inventories 0,0.00
(Increase) Decrease In Other Current Assets 0,0.00
(Decrease) Increase In Other Current Liabilities 0,0.00
(Increase) Decrease In Other Working Capital 0,0.00
Other Non-Cash Items 0,0.00
Net Cash From Continuing Operations 0,0.00
Net Cash From Discontinued Operations 0,0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 0,0.00
Sale Of Property, Plant & Equipment 0,0.00
Cash Used For Investing Activities
Sale Of Short-Term Investments 0,0.00
Purchases Of Property, Plant & Equipment 0,0.00
Acquisitions 0,0.00
Purchases Of Short-Term Investments 0,0.00
Other Cash From Investing Activities 0,0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities 0,0.00
Issuance Of Debt 0,0.00
Cash Used For Financing Activities
Issuance Of Capital Stock 0,0.00
Repayment Of Long-Term Debt 0,0.00
Repurchase Of Capital Stock 0,0.00
Payment Of Cash Dividends 0,0.00
Other Financing Charges, Net 0,0.00
Net Cash From Financing Activities 0,0.00
Effect Of Exchange Rate Changes 0,0.00
Net Change In Cash & Cash Equivalents 0,0.00

Earnings Estimates

as of 3:59 ET PM 10/25/2021
Current Qtr
(12/1969)
Next Qtr
(12/1969)
Consensus Estimate n/a n/a
# of Estimates n/a n/a
High Estimate n/a n/a
Low Estimate n/a n/a
Year Ago EPS n/a n/a
Year Over Year Growth Estimate n/a n/a
Current Yr
(12/1969)
Next Yr
(12/1969)
Consensus Estimate n/a n/a
# of Estimates n/a n/a
High Estimate n/a n/a
Low Estimate n/a n/a
Year Ago EPS n/a n/a
Year Over Year Growth Estimate n/a n/a
Current Qtr
(12/1969)
Next Qtr
(12/1969)
Current Year
(12/1969)
Next Year
(12/1969)
Consensus Estimate n/a n/a n/a n/a
# of Estimates n/a n/a n/a n/a
High Estimate n/a n/a n/a n/a
Low Estimate n/a n/a n/a n/a
Year Ago EPS n/a n/a n/a n/a
Year Over Year Growth Estimate n/a n/a n/a n/a

Insider Information Summary

as of n/a
% Insiders - n/a
% Remaining Total Shares - n/a
Current 1 Month
Net Insider Transaction n/a n/a
Shares Bought n/a n/a
Shares Sold n/a n/a

Insider Activity

Transaction Date Insider/Title Transaction Type Market Value Shares Average Price Current Holdings

LATEST NEWS

Recent Articles from TheStreet

Tesla Lead

Tesla Must Do 2 Things to Meet $1,500 Bull Case: Wedbush

Tesla crossed the trillion-dollar valuation mark. Wedbush's Dan Ives and John Katsingris see 2 things it must do to meet their most bullish scenario.

Tesla Model 3 Lead

Tesla Takes Heat From NTSB Chief Homendy Over Self-Driving

NTSB Chairwoman Jennifer Homendy criticized Tesla for labeling its driver-assistance systems 'full self-driving.'

Facebook Lead

Facebook Stock Slips as Analysts Maintain Cautious Support

Facebook's third-quarter results were 'better than feared,' one analyst says.

Otis Worldwide Lead

Otis Quadruples Estimate of Inflation Impact on Earnings

Elevator/escalator titan Otis raised its estimate for the impact of commodity-price inflation on its results to four times its estimate from February.

JetBlue Lead

JetBlue Stock Rises After Swing to Surprise Profit, Revenue Jump

JetBlue said it expected a full recovery as demand was poised to reaccelerate into the peak holiday periods.

Pfizer Covid-19 Vaccine Lead

Pfizer, BioNTech Children's Vaccine Reviewed by FDA Advisory Group

The Vaccines and Related Biological Products Advisory Committee will review data and recommend whether the FDA should authorize use.

Coinbase is a cryptocurrency exchange platform

Coinbase Stock Slips; Citi Initiates at Buy, Sees Wider Product Line

Coinbase is positioned to make 'higher highs and higher lows' as crypto adoption increases, Citi says.

Microsoft Azure Lead

Big-Tech Earnings Preview – What Investors Should Watch For

Earnings season got off to a strong start. Now, the fireworks begin as big tech reports. Here's what investors should know.

Midday Wrap: Trade Talks, Beyond Meat Bears

Beyond Meat Stock Off; Credit Suisse Cuts Market-Share Outlook

Beyond Meat's 'revenue miss in Q3 reinforces our view' that the company 'is reaching market saturation faster than expected,' Credit Suisse says.

Eli Lilly Lead

Raytheon Posts Mixed Quarter and Raises Profit Guidance

Raytheon beats on third-quarter earnings but misses on sales; expects increased aerospace demand to help its bottom line as travel becomes less restricted.